Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
AMA J Ethics ; 18(12): 1207-1217, 2016 Dec 01.
Article in English | MEDLINE | ID: mdl-28009247

ABSTRACT

Early detection of Alzheimer's disease (AD) raises a number of challenging legal questions. In this essay, we explore some of those questions, such as: Is a neurological indicator of increased risk for AD a legally relevant brain state before there are any outward behavioral manifestations? How should courts address evidentiary challenges to the admissibility of AD-related neuroimaging? How should the government regulate the marketing of neuroimaging diagnostic tools? How should insurance coverage for the use of these new tools be optimized? We suggest that many voices and multidisciplinary perspectives are needed to answer these questions and ensure that legal responses are swift, efficient, and equitable.


Subject(s)
Alzheimer Disease/diagnosis , Brain/diagnostic imaging , Judicial Role , Neuroimaging/methods , Alzheimer Disease/diagnostic imaging , Behavior , Biomarkers , Early Diagnosis , Humans , Insurance Coverage , Marketing , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...